P-073 - A PBPK/PD MODEL FOR ADDITION OF CPY3A4 AND P-GP INHIBITORS TO RELUGOLIX FOR ANDROGEN DEPRIVATION THERAPY.

P. Hsieh, M. Dreyer, W. Stadler, M. Ratain; The University of Chicago, Chicago, IL, USA.

Presenting Author(s)

Po-Hung Hsieh, PhD

Senior Clinical Pharmacologist
The University of Chicago, Illinois, United States